Current advanced technologies for genetic analysis have created almost unimaginable amounts of data, measured in “petabytes” – a petabyte is a million billion bytes. Genomic researchers are keen to analyze these data and identify genetic clues that could point to new ways to prevent or cure cancer.
Today Canada’s genomics enterprise marks the landmark discovery of DNA’s double helix structure, published in Nature by James Watson and Francis Crick in April 1953. The discovery – arguably one of the most important of the 20th century – answered a fundamental mystery about how living organisms pass genetic instructions from generation to generation, and eventually enabled later researchers to understand the genetic code.
How does environment impact human health and natural resources at the genomic level? How can genomics help leverage Canada's traditional resource sectors while preserving the environment?
Explore these questions and more with world-renowned genomics experts and visionaries from academia, industry, government and media. A poster session highlighting the work of graduate students and post-doctoral fellows will also be featured.
The Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM), in collaboration with the Maisonneuve-Rosemont Hospital’s Quebec Leukemia Cell Bank, recently achieved a significant breakthrough thanks to the laboratory growth of leukemic stem cells, which will speed up the development of new cancer drugs.
A new web portal – PhenomeCentral – is being launched today to connect clinicians and scientists worldwide in an effort to speed the discovery of genes responsible for rare disorders.
Members of the Cancer Stem Cell Consortium (CSCC) today congratulated Dr. John Dick, a Senior Scientist at the University Health Network and Director of the Cancer Stem Cell Program of the Ontario Institute for Cancer Research, on major new findings published today in the journal Nature.